Bio Essence Corporation
BIOE
$0.23
$0.0188.49%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -163.75% | -43.93% | -57.85% | 22.34% | 12.75% |
| Total Depreciation and Amortization | -70.37% | -74.47% | -349.15% | -222.22% | -55.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8,729.82% | 497.02% | 366.47% | -68.52% | -108.74% |
| Change in Net Operating Assets | 452.82% | 414.80% | 242.63% | 28.19% | -130.16% |
| Cash from Operations | 179.69% | 160.83% | 99.65% | 4.21% | -41.90% |
| Capital Expenditure | -- | -- | -100.00% | -63.64% | 2.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 99.89% | 99.89% | -865.93% | -58.85% | -54.82% |
| Total Debt Issued | -86.55% | -100.00% | -68.29% | -5.63% | 45.15% |
| Total Debt Repaid | -8,542.06% | -47,061.54% | -346.74% | 188.09% | -729.41% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 86.34% | -1,014.74% | -1,014.74% | -1,014.74% |
| Cash from Financing | -172.79% | -156.03% | -87.39% | 1.45% | 42.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 119.67% | 6,080.00% | 1,720.00% | -- |